Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07501806 · ClinicalTrials.gov registry record · NA

Effect of the Combination of Nitrate and Caffeine on Critical Power In Trained Male Cyclists

A NA study, sponsored by Lindenwood University.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT07501806: Completed NA study, sponsored by Lindenwood University.

NCT07501806 is a NA study that has completed, run by Lindenwood University. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07501806, a NA study, has completed, sponsored by Lindenwood University.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

This study is investigating the independent and combined effects of acute dietary nitrate and caffeine supplementation on performance during a 3-minute all-out cycling test in trained male cyclists. In a randomized, double-blind, placebo-controlled, crossover design, participants will complete four experimental conditions: nitrate, caffeine, nitrate plus caffeine, and placebo. Primary outcomes include end power (EP) and work done above end power (WEP), surrogate measures of critical power and W'. The study aims to determine whether combined supplementation provides additive benefits for severe-intensity exercise performance.

Primary Outcome

End power (EP) will be determined as the average power output over the final 30 seconds of the 3-minute all-out cycling test and will be used as a surrogate measure of critical power.

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Caffeine
  • DIETARY_SUPPLEMENT Dietary Nitrate

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2020-11-17
Est. Completion 2021-11-11
Phase NA
Lindenwood University

29 total trials

What the finished NCT07501806 record still lists

NCT07501806 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT07501806 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07501806 about?

NCT07501806 is a clinical study titled "Effect of the Combination of Nitrate and Caffeine on Critical Power In Trained Male Cyclists". This study is investigating the independent and combined effects of acute dietary nitrate and caffeine supplementation on performance during a 3-minute all-out cycling test in trained male cyclists. In a randomized, double-blind, placebo-controlled, crossover design, participants will complete four ...

What is the current status of trial NCT07501806?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2020-11-17. Estimated completion is 2021-11-11.

What interventions are being tested in trial NCT07501806?

The interventions under investigation include: Placebo (OTHER), Caffeine (DIETARY_SUPPLEMENT), Dietary Nitrate (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07501806?

This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07501806's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07501806, the US trial registry maintained by the National Library of Medicine. NCT07501806 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.